Table 1. RKIP expression in cervical lesions.
| RKIP Expression | |||||
| Type of Lesion | N | Negative (%) | Positive (%) | p | |
| Cervicitis | 45 | 16 (35.6) | 29 (64.5) | ||
| LSIL | |||||
| CIN1 | 47 | 26 (55.3) | 21 (44.7) | ||
| HSIL | |||||
| CIN2 | 16 | 6 (37.5) | 10 (62.5) | ||
| CIN3 | 27 | 14 (51.9) | 13 (48.1) | ||
| LSIL | 47 | 26 (55.3) | 21 (44.7) | 0.404 | |
| HSIL | 43 | 20 (46.5) | 23 (53.5) | ||
| Invasive Carcinoma | |||||
| AC | 40 | 33 (80.5) | 8 (19.5) | 0.643 | |
| SCC | 70 | 61 (87.1) | 9 (12.9) | ||
| ASC | 13 | 11 (84.6) | 2 (15.4) | ||
| Cervicitis | 45 | 16 (35.6) | 29 (64.5) | 0.087 | |
| SIL | 90 | 46 (51.1) | 44 (48.9) | ||
| Benign Lesions | 135 | 62 (46.0) | 73 (54.0) | <0.001 | |
| Cervical Cancer | 124 | 105 (84.7) | 19 (15.3) | ||
Cervical intraepithelial neoplasia (CIN); Low-grade squamous intraepithelial lesions (LSIL); high-grade squamous intraepithelial lesions (HSIL); squamous cell carcinomas (SCC); adenocarcinomas (AC); adenosquamous carcinomas (ASC).